PLURISTEM THERA (NASDAQ:PSTI)
1.14
0.02 (1.72%)
| PLURISTEM THERA (NASDAQ:PSTI) Delayed : |
| Previous Close |
$1.16 |
|
52 Week High |
$2.29 |
|
| Open |
$1.16 |
|
52 Week Low |
$0.30 |
| Day High |
$1.16 |
|
P/E |
N/A |
| Day Low |
$1.09 |
|
EPS |
$-0.48 |
| Volume |
72,735 |
|
|
|
| More PSTI Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on PSTI
-
Nov 17, 2009 08:25 AM
Pluristem Therapeutics (PSTI) Announces Safety and Efficacy Parameters for PLX-PAD Placenta Cell Therapy
-
Oct 6, 2009 01:06 PM
Unusual 11 Mid-Day Movers 10/06: FONR, ICTG, ACAD, AVCT Higher; MNKD, VRNMD, ARP, PPD Lower
-
Oct 6, 2009 10:36 AM
Morning Movers 10/06: FONR, ICTG, PEDH, AVCT, SRDX, NTRI Higher; VRNMD, MNKD, ARP, PSTI, EXTR, STJ Lower
-
Oct 6, 2009 10:01 AM
Pluristem Therapeutics (PSTI) Sells 2.7M Shares at $1.12, With Warrants to Boot
-
Oct 2, 2009 08:16 AM
Pluristem (PSTI) Provides Disclosure Pursuant to NASDAQ Marketplace Rule 5250
View All Reports
StreetInsider Reports on PSTI by Category
Comments on recent PSTI articles
Comments on PSTI
No comments are currently available.
on Mar 2, 2009
at 06:16 PM RE: SCLL PSTI SEEMS TO GET CREDIT FOR WORK SCLL DOES, WHY? BECAUSE THEY ARE THE PARENT COMPANY?
Article: Pluristem Therapeutics (PSTI) Announces Clearance for "First-In-Human" Placenta-Derived Stem Cell Clinical Trial